Financhill
Back

EPAM Systems Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
4

EPAM
EPAM Systems

Last Price:
$164.96
Seasonality Move:
13.08%
Sell
33

APLS
Apellis Pharmaceuticals

Last Price:
$17.77
Seasonality Move:
-0.62%
Sell
4
EPAM Systems (EPAM) is a Sell

Is EPAM Systems a Buy, Sell or Hold?

  • The current EPAM Systems [EPAM] share price is $165.02. The Score for EPAM is 4, which is 92% below its historic median score of 50, and infers higher risk than normal.
  • EPAM is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
33
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $17.76. The Score for APLS is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EPAM Stock Price Chart

What is EPAM Systems's stock price today?

  • The EPAM Systems share price today is $165.02
    The current trend is moderately bearish and EPAM is experiencing selling pressure, which indicates risk of future bearish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $17.76
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight buying pressure.

EPAM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.88 Buy
Relative Strength Index (14 RSI): 38.79 Sell
Chaikin Money Flow: -438903 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (171.54 - 182.2) Sell
Bollinger Bands (100): (153.55 - 226.65) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 43.51 Sell
Chaikin Money Flow: 37954 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.12 - 19.06) Sell
Bollinger Bands (100): (17.79 - 26.73) Sell

EPAM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 173.35 Sell
20-day SMA: 174.97 Sell
50-day SMA: 167.6 Sell
200-day SMA: 204.27 Sell
8-day EMA: 171.52 Sell
20-day EMA: 173.16 Sell
50-day EMA: 157.67 Buy
200-day EMA: 78.8 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.77 Sell
20-day SMA: 18.28 Sell
50-day SMA: 18.29 Sell
200-day SMA: 26.93 Sell
8-day EMA: 18.41 Sell
20-day EMA: 18.43 Sell
50-day EMA: 19.3 Sell
200-day EMA: 27.06 Sell

EPAM Systems Earnings Growth & EPAM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.64 per share, an increase next quarter of $0.06 per share, a decrease this year of $0.04 per share, and an increase next year of $1.22 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.18 per share, a decrease this year of $0.14 per share, and an increase next year of $1.12 per share.

EPAM Systems Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):